Nancy Miller Rich Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

Nancy Miller Rich is Director of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 8,111 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $154,109. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Nancy Miller-Rich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Sale (or disposition) back to the issuer	$154,109 $19.0 p/Share	8,111 Reduced 100.0%	0 Common Stock
Nov 08 2023	SELL Disposition due to a tender of shares in a change of control transaction	$423,776 $19.0 p/Share	22,304 Reduced 100.0%	0 Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	8,111 Added 21.05%	30,415 Common Stock
May 25 2022	BUY Grant, award, or other acquisition	-	7,737 Added 25.75%	22,304 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	7,029 Added 32.55%	14,567 Common Stock

Also insider at

FDMT

4D Molecular Therapeutics, Inc. Healthcare

ALDX

Aldeyra Therapeutics, Inc. Healthcare

KDMN

Kadmon Holdings, Inc.

Director